Click on the sample link below to view complete table of contents and select pages.
The following information is included for the top 50 pharmaceutical companies, which were determined based on their healthcare revenue generated during 2008:
- Each pipeline products’ chemical or substance composition, intended indication, clinical status, region of development, and developer/marketer
- Pipeline status details preclinical development, Phase I, Phase II, Phase III, and awaiting approval
- Region of development includes the U.S., Europe, and Japan
- Select 2008 and 2007 financial data such as revenue, net income, earnings per share, and R&D expenditure
The report overview highlights news updates and overall status for the leading company pipelines. Plus, some of the most-anticipated medicines in clinical development are detailed in the Products to Watch section, which includes facts & figures about each drug and their potential market competition.